Ventricular Assist Devices Market by Product, Application, and Design - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580550
  • Report
  • Region: Global
  • 190 pages
  • Allied Analytics LLP
1 of 4
Ventricular assist device is a mechanical pump used to support the function of left, right, or both ventricles. These devices are used to support cardiac circulation in people who have reached the end-stage heart failure. The global ventricular assist devices market garnered $809 million in 2016, and is anticipated to reach $1,773 million, growing at a CAGR of 11.8%.

Growth in incidences of heart failure across the globe, new technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and shortage of heart donors drive the market. Moreover, emerging countries such as developing and under-developed nations provide lucrative opportunities for the market to witness growth. However, the market is restrained by high cost of the procedure and certain risks associated with the VAD implantation procedure.

The global ventricular assist devices market is segmented into product, application, design, and region. Based on product, it is divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). By application, the market is classified into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. Based on design, the market is bifurcated into transcutaneous and implantable ventricular assist devices. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report provides an extensive analysis of the current and emerging trends and dynamics in the global ventricular assist devices market.
  • This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
  • This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS

By Product
  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)
By Application
  • Bridge-to-transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-to-recovery (BTR) Therapy
  • Bridge-to-candidacy (BTC) Therapy
By Design
  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
The key players profiled in this report are as follows:
  • Abiomed, Inc.
  • Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
  • Abbott Laboratories (St. Jude Medical, Inc.)
  • Berlin Heart GmbH
  • Calon Cardio-Technology Ltd.
  • CardiacAssist Technologies
  • Jarvik Heart, Inc.
  • Medtronic plc
  • ReliantHeart, Inc.
  • Terumo Medical Corporation
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.1.1. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
3.2.1.2. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
3.2.1.3. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
3.2.2. Top investment pockets
3.3. Market share analysis, 2016
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of heart failures
3.4.1.2. Technological advancements
3.4.1.3. Increase in patient awareness about heart failure treatment options
3.4.1.4. Dearth of heart donors
3.4.2. Restraints
3.4.2.1. High cost of devices and procedures
3.4.2.2. Serious risks involved in the procedure
3.4.3. Opportunity
3.4.3.1. Lucrative opportunities in the emerging markets
3.4.4. Impact analysis

CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Left ventricular assist devices (LVADs)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Right ventricular assist devices (RVADs)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Biventricular assist devices (BIVADs)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Bridge-to-transplant (BTT) therapy
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Destination therapy
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Bridge-to-recovery (BTR) therapy
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Bridge-to-candidacy (BTC) therapy
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN
6.1. Overview
6.1.1. Market size and forecast
6.2. Transcutaneous ventricular assist devices
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Implantable ventricular assist devices
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

CHAPTER 7: VENTRICULAR ASSIST DEVICES, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. ventricular assist devices market size and forecast
7.2.2.1.1. U.S. ventricular assist devices market size and forecast, by product
7.2.2.1.2. U.S. ventricular assist devices market size and forecast, by application
7.2.2.1.3. U.S. ventricular assist devices market size and forecast, by design
7.2.2.2. Canada ventricular assist devices market size and forecast
7.2.2.2.1. Canada ventricular assist devices market size and forecast, by product
7.2.2.2.2. Canada ventricular assist devices market size and forecast, by application
7.2.2.2.3. Canada ventricular assist devices market size and forecast, by design
7.2.2.3. Mexico ventricular assist devices market size and forecast
7.2.2.3.1. Mexico ventricular assist devices market size and forecast, by product
7.2.2.3.2. Mexico ventricular assist devices market size and forecast, by application
7.2.2.3.3. Mexico ventricular assist devices market size and forecast, by design
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by design
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany ventricular assist devices market size and forecast
7.3.2.1.1. Germany ventricular assist devices market size and forecast, by product
7.3.2.1.2. Germany ventricular assist devices market size and forecast, by application
7.3.2.1.3. Germany ventricular assist devices market size and forecast, by design
7.3.2.2. France ventricular assist devices market size and forecast
7.3.2.2.1. France ventricular assist devices market size and forecast, by product
7.3.2.2.2. France ventricular assist devices market size and forecast, by application
7.3.2.2.3. France ventricular assist devices market size and forecast, by design
7.3.2.3. UK ventricular assist devices market size and forecast
7.3.2.3.1. UK ventricular assist devices market size and forecast, by product
7.3.2.3.2. UK ventricular assist devices market size and forecast, by application
7.3.2.3.3. UK ventricular assist devices market size and forecast, by design
7.3.2.4. Italy ventricular assist devices market size and forecast
7.3.2.4.1. Italy ventricular assist devices market size and forecast, by product
7.3.2.4.2. Italy ventricular assist devices market size and forecast, by application
7.3.2.4.3. Italy ventricular assist devices market size and forecast, by design
7.3.2.5. Spain ventricular assist devices market size and forecast
7.3.2.5.1. Spain ventricular assist devices market size and forecast, by product
7.3.2.5.2. Spain ventricular assist devices market size and forecast, by application
7.3.2.5.3. Spain ventricular assist devices market size and forecast, by design
7.3.2.6. Rest of Europe ventricular assist devices market size and forecast
7.3.2.6.1. Rest of Europe ventricular assist devices market size and forecast, by product
7.3.2.6.2. Rest of Europe ventricular assist devices market size and forecast, by application
7.3.2.6.3. Rest of Europe ventricular assist devices market size and forecast, by design
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by design
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan ventricular assist devices market size and forecast
7.4.2.1.1. Japan ventricular assist devices market size and forecast, by product
7.4.2.1.2. Japan ventricular assist devices market size and forecast, by application
7.4.2.1.3. Japan ventricular assist devices market size and forecast, by design
7.4.2.2. China ventricular assist devices market size and forecast
7.4.2.2.1. China ventricular assist devices market size and forecast, by product
7.4.2.2.2. China ventricular assist devices market size and forecast, by application
7.4.2.2.3. China ventricular assist devices market size and forecast, by design
7.4.2.3. India ventricular assist devices market size and forecast
7.4.2.3.1. India ventricular assist devices market size and forecast, by product
7.4.2.3.2. India ventricular assist devices market size and forecast, by application
7.4.2.3.3. India ventricular assist devices market size and forecast, by design
7.4.2.4. Australia ventricular assist devices market size and forecast
7.4.2.4.1. Australia ventricular assist devices market size and forecast, by product
7.4.2.4.2. Australia ventricular assist devices market size and forecast, by application
7.4.2.4.3. Australia ventricular assist devices market size and forecast, by design
7.4.2.5. Rest of Asia-Pacific ventricular assist devices market size and forecast
7.4.2.5.1. Rest of Asia-Pacific ventricular assist devices market size and forecast, by product
7.4.2.5.2. Rest of Asia-Pacific ventricular assist devices market size and forecast, by application
7.4.2.5.3. Rest of Asia-Pacific ventricular assist devices market size and forecast, by design
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by design
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil ventricular assist devices market size and forecast
7.5.2.1.1. Brazil ventricular assist devices market size and forecast, by product
7.5.2.1.2. Brazil ventricular assist devices market size and forecast, by application
7.5.2.1.3. Brazil ventricular assist devices market size and forecast, by design
7.5.2.2. South Africa ventricular assist devices market size and forecast
7.5.2.2.1. South Africa ventricular assist devices market size and forecast, by product
7.5.2.2.2. South Africa ventricular assist devices market size and forecast, by application
7.5.2.2.3. South Africa ventricular assist devices market size and forecast, by design
7.5.2.3. Saudi Arabia ventricular assist devices market size and forecast
7.5.2.3.1. Saudi Arabia ventricular assist devices market size and forecast, by product
7.5.2.3.2. Saudi Arabia ventricular assist devices market size and forecast, by application
7.5.2.3.3. Saudi Arabia ventricular assist devices market size and forecast, by design
7.5.2.4. Rest of LAMEA ventricular assist devices market size and forecast
7.5.2.4.1. Rest of LAMEA ventricular assist devices market size and forecast, by product
7.5.2.4.2. Rest of LAMEA ventricular assist devices market size and forecast, by application
7.5.2.4.3. Rest of LAMEA ventricular assist devices market size and forecast, by design
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by design

CHAPTER 8: COMPANY PROFILES
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Abbott Laboratories (St. Jude Medical, Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Berlin Heart GmbH
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.5. Calon Cardio-Technology Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.6. CardiacAssist Technologies
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.7. Jarvik Heart, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Key strategic moves and developments
8.8. Medtronic Plc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. ReliantHeart, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Key strategic moves and developments
8.10. Terumo Corporation
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, " Ventricular Assist Devices Market by Product, Application, and Designlobal Opportunity Analysis and Industry Forecast, 2017-2023," the global ventricular assist devices market was valued at $809 million in 2016, and is estimated to reach $1,773 million by 2023, growing at a CAGR of 11.8% from 2017 to 2023.

Ventricular assist device (VAD) is used to assist a damaged or weakened heart in pumping blood. The device is surgically attached to one or both intact ventricles and thus assists cardiac circulation.

The major factors that contribute to the market growth include technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and treatment options for management of cardiac disorders. Moreover, increased presence unmet medical needs in the developing and the under developed regions of the world is anticipated to provide lucrative opportunities for the market growth. However, the main challenge in the market is high cost of the VAD procedure. Also, bleeding complications and other associated risks hamper the growth of the ventricular assist devices market.

By product, LVADs accounted for the major share of the global ventricular assist devices market in 2016. By application segment, bridge-to-transplant generated the maximum revenue, thus accounting for more than 49% of the global ventricular assist devices market in 2016. In addition, destination therapy segment is expected to witness the highest CAGR of 13.4% during the forecast period. By design, implantable ventricular assist device dominated the market with three-fourths share in the global ventricular assist devices market in 2016.

Key Findings of the Ventricular Assist Devices Market

The left ventricular assist devices (LVADs) segment is projected to grow at a significant CAGR of 11.7%, during the forecast period (2017-2023).
Transcutaneous ventricular assist device is projected to grow at a significant CAGR, during the forecast period.
Destination therapy accounted for more than one-fourth share of the global market in 2016.
Germany and France are the major shareholders, and together accounted for more than one-third share of the European market in 2016.
Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific market in 2016.

The Asia-Pacific market is projected to grow at the highest CAGR of 14.9% during the forecast period, owing to increase in awareness about the benefits of digital wound measurement devices in healthcare industry and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Calon Cardio-Technology Ltd., CardiacAssist Technologies, Jarvik Heart, Inc., Medtronic plc, ReliantHeart, Inc., and Terumo Medical Corporation.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll